GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Omega Alpha SPAC (NAS:OMEG) » Definitions » Valuation Rank

Omega Alpha SPAC (Omega Alpha SPAC) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Omega Alpha SPAC Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Omega Alpha SPAC Valuation Rank Related Terms

Thank you for viewing the detailed overview of Omega Alpha SPAC's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Omega Alpha SPAC (Omega Alpha SPAC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Omega Alpha SPAC (NAS:OMEG) » Definitions » Valuation Rank
Comparable Companies
FLAC GSQB LJAQ PRBM MURF ITAQ SGII APCA JATT GLTA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
888 Boylston Street, Suite 1111, Boston, MA, USA, 02199
Website
Omega Alpha SPAC is a blank check company.
Executives
Otello Stampacchia director, 10 percent owner, officer: Chief Executive Officer 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Alpha Management Omega 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02119
Joseph P Slattery director C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Martin Babler director C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Daniel Lynch director
Vincent Ossipow officer: Chief Scientific Officer CH. DES VIGNES 1, COMMUGNY V8 1291
Van De Winkel Jan director C/O HOOKIPA PHARMA INC., 430 EAST 29TH STREET 14TH FLOOR, NEW YORK NY 10016
Omega Fund Vi, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp Manager, Ltd. 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp, L.p. 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Michelle Doig director, officer: President C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Francesco Draetta officer: Chief Financial Officer C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Alexandra Pearsall 10 percent owner C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199